Cargando…

Surveillance of women at high risk for hereditary ovarian cancer is inefficient

To determine the effectiveness of annual gynaecological screening (pelvic examination, transvaginal ultrasound, and CA-125), a prospective cohort study of women at high risk for hereditary ovarian cancer was conducted. Women were offered DNA analysis followed by either annual screening or prophylact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oei, A L, Massuger, L F, Bulten, J, Ligtenberg, M J, Hoogerbrugge, N, de Hullu, J A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361371/ https://www.ncbi.nlm.nih.gov/pubmed/16495917 http://dx.doi.org/10.1038/sj.bjc.6603015

Ejemplares similares

Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
por: Oei, A L M, et al.
Publicado: (2006)

Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities
por: de Bie, R P, et al.
Publicado: (2009)

Risk factors for short- and long-term complications after groin surgery in vulvar cancer
por: Hinten, F, et al.
Publicado: (2011)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
por: Gerritzen, Lotte H. M., et al.
Publicado: (2009)

DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women
por: Boers, A, et al.
Publicado: (2014)

The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single‐centre study
por: Pouwer, AW, et al.
Publicado: (2018)

Adequacy of family history taking in ovarian cancer patients: a population-based study
por: van Altena, Anne M., et al.
Publicado: (2012)

Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic
por: Donnelly, L S, et al.
Publicado: (2014)

Cytology of the vulva: feasibility and preliminary results of a new brush
por: van den Einden, L C G, et al.
Publicado: (2012)

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
por: Koopman, M, et al.
Publicado: (2009)

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing
por: Witjes, Vera M., et al.
Publicado: (2021)

Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies
por: te Paske, Iris B. A. W., et al.
Publicado: (2020)

Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening
por: Fallowfield, L, et al.
Publicado: (2010)

Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer
por: Liljegren, Annelie, et al.
Publicado: (2018)

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
por: Hermsen, B B J, et al.
Publicado: (2007)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review
por: Rettenmaier, N B, et al.
Publicado: (2010)

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
por: Witjes, Vera M., et al.
Publicado: (2022)

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
por: Wright, J D, et al.
Publicado: (2008)

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
por: Pearce, C L, et al.
Publicado: (2008)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2006)

Ovarian Cyst Fluid of Serous Ovarian Tumors Contains Large Quantities of the Brain Amino Acid N-acetylaspartate
por: Kolwijck, Eva, et al.
Publicado: (2010)

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)

The Effect of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Hereditary Spastic Paraplegia
por: Antczak, J., et al.
Publicado: (2019)

SEOM clinical guidelines in Hereditary Breast and ovarian cancer
por: Llort, G., et al.
Publicado: (2015)

Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
por: Vogelaar, Ingrid P, et al.
Publicado: (2012)

Predictors of ovarian reserve in young women with breast cancer
por: Lutchman Singh, K, et al.
Publicado: (2007)

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer
por: van Bommel, Majke H.D., et al.
Publicado: (2022)

Multimodal Imaging in Hereditary Retinal Diseases
por: Pichi, Francesco, et al.
Publicado: (2013)

Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk
por: Apicella, C, et al.
Publicado: (2009)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
por: Huang, Ying, et al.
Publicado: (2014)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer
por: Phillips, Kelly-Anne, et al.
Publicado: (2016)

Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue
por: van de Nieuwenhof, Hedwig P., et al.
Publicado: (2010)

Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study
por: Sayasneh, A, et al.
Publicado: (2016)

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome
por: Reijnen, Casper, et al.
Publicado: (2020)

Thrombosis in ovarian cancer: a case control study
por: Metcalf, R L, et al.
Publicado: (2014)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
por: Griebsch, I, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ppgj4ul92okvkgu511m2rsgahq